Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CD5 B cells and B-cell malignancies

P M Lydyard1, A P Jewell, C Jamin

  • 1Department of Immunology, UCL Medical School, London, United Kingdom.

Current Opinion in Hematology
|January 23, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Within patient horizontal gene transfer dynamics of a bla<sub>NDM-7</sub> plasmid among four different bacterial species.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2025
Same author

[The MASK lift].

Annales de chirurgie plastique et esthetique·2024
Same author

Role of the environment in transmission of Gram-negative bacteria in two consecutive outbreaks in a haematology-oncology department.

Infection prevention in practice·2022
Same author

Epidemiological, clinical, and echocardiographic features, and outcome of dogs with Ebstein's anomaly: 32 cases (2002-2016).

Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology·2020
Same author

Assessment of bovine tuberculosis surveillance effectiveness in French wildlife: An operational approach.

Preventive veterinary medicine·2020
Same author

[Is AMH a fertility marker?]

Gynecologie, obstetrique, fertilite & senologie·2019
Same journal

Dynamic myeloid suppressor states in cancer and inflammation and their therapeutic potential.

Current opinion in hematology·2026
Same journal

Factor XIa inhibition for the prevention of thrombosis: mechanism, clinical trial signals, and indication-specific positioning.

Current opinion in hematology·2026
Same journal

Nutrition as a regulator of hematopoietic stem cell biology and transplantation.

Current opinion in hematology·2026
Same journal

From biomimicry to clinical actionability: rethinking high-shear thrombosis as a mechanobiological system.

Current opinion in hematology·2026
Same journal

Bidirectional relationship between metabolic and thrombotic disease mechanisms.

Current opinion in hematology·2026
Same journal

The dual role of the brain-derived neurotrophic factor as a regulator of hemostasis and thrombotic risk.

Current opinion in hematology·2026
See all related articles

Recent research advances understanding of CD5+ B1 cells and their role in diseases like B-cell chronic lymphocytic leukemia. New insights into CD5 signaling, tumor suppressors, and immune dysfunction offer progress in diagnosis and treatment.

Area of Science:

  • Immunology
  • Hematology
  • Oncology

Background:

  • CD5+ B1 cells play a role in disease pathogenesis, though their exact function is still under investigation.
  • The negative regulatory function of CD5 within the B-cell receptor complex is supported by recent studies.
  • Advances in understanding CD5+ malignancies, especially B-cell chronic lymphocytic leukemia (CLL), have been made.

Purpose of the Study:

  • To review recent progress in the physiology, disease associations, and pathogenesis of CD5+ B1 cells.
  • To highlight advancements in the diagnosis and understanding of CD5+ malignancies, particularly CLL.
  • To discuss new findings related to CD5 signaling, genetic factors, and immune dysfunction in CLL.

Main Methods:

  • Review of recent scientific literature on CD5+ B1 cell research.

Related Experiment Videos

  • Analysis of studies investigating CD5 signaling pathways and coreceptor function.
  • Examination of research on genetic mutations and molecular alterations in CLL.

    • Main Results:

    • Substantiation of CD5's negative regulatory role in B-cell receptor signaling.
    • Identification of mutations in CD79b explaining low surface immunoglobulin expression in CLL.
    • Discovery of two novel tumor-suppressor genes on chromosome 13q linked to CLL etiopathogenesis.
    • Observation of differential phosphorylation of STAT molecules in B1 and CLL cells.
    • Evidence suggesting aberrant CD40L expression on CLL T cells contributes to immunodeficiency.

    Conclusions:

    • Significant progress has been made in understanding CD5+ B1 cell physiology and disease associations, particularly in CLL.
    • New genetic and molecular insights are advancing the understanding of CLL pathogenesis and potential therapeutic targets.
    • Further research is needed to elucidate the precise significance of observed signaling pathway alterations and their clinical implications.